相关实验视频

Updated: Jul 10, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

多发性骨髓瘤中CAR-T细胞疗法:B细胞成熟抗原 (BCMA) 和超越

Abhinava K Mishra¹, Ashna Gupta², Gunjan Dagar²

¹Molecular, Cellular and Developmental Biology Department, University of California Santa Barbara, Santa Barbara, CA 93106, USA.

|November 25, 2023

概括

化学抗原受体T细胞 (CAR-T) 疗法对多发性骨髓瘤 (MM) 是有前途的,其向B细胞成熟抗原 (BCMA). 抗原逃逸和毒性等挑战仍然是广泛用于复发性和耐火性MM的障碍.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
血液学血液学血液学

背景情况:

多发性骨髓瘤 (MM) 治疗已经取得进展,但治疗复发性/耐药性MM (RRMM) 的方法仍然难以捉摸.
传统疗法对先进的MM提供了有限的成功.
采用细胞疗法,特别是CAR-T疗法,正在成为一种强有力的策略.

研究的目的:

审查在MM中CAR-T治疗的疗效和挑战.
突出B细胞成熟抗原 (BCMA) 作为MM中CAR-T治疗的关键标.
讨论其他目标和实施障碍.

主要方法:

对MM的CAR-T治疗临床研究的综述.
对BCMA和其他向抗原 (SLAMF7,CD38,CD19,CS1,NKG2D,CD138) 的分析.
对CAR-T疗法的临床疗效和局限性的评估.

主要成果:

针对BCMA和其他抗原的CAR-T疗法在MM患者中显示出临床疗效.
在纵向后续研究中观察到抗原逃逸.
显著的挑战阻碍了广泛的CAR-T疗法实施.

结论:

卡特-T疗法,特别是针对BCMA,代表了MM治疗的重大进展.
克服抗原逃逸,毒性和后勤问题等挑战对于更广泛的应用至关重要.
需要进一步的研究来优化CAR-T疗法,以实现持久的MM缓解.

关键词:

B细胞成熟抗原 (BCMA) 是一种使用CAR-T细胞治疗.多发性骨髓瘤 (MM) 是一种

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...